A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...

Researchers wanted to see if switching from a weekly to a biweekly jab could help people maintain their weight loss. The ...

Medicines such as semaglutide, which are sold under brand names like Wegovy and Ozempic, help people lose weight by reducing appetite and slowing digestion. These drugs work by copying the action of a ...

SLIMMERS who use weight loss jabs pile almost two thirds of the flab they lose within a year, research suggests. Around ...

A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing ...

Study finds GLP-1 weight-loss drugs may improve eating behavior by reducing cravings triggered by emotions, advertisements, and environmental cues.

A fascinating simulation shows how GLP-1 and GIP drugs such as Ozempic, Mounjaro and Wegovy help people lose weight.

Exercise can stimulate appetite, leading to increased food intake. People may also subconsciously move less throughout the rest of the day after doing a workout, which means exercise may have less ...

While GLP-1 drugs are effective for shedding pounds, there are concerns about potential risks and long-term effects.

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.